|
ATP6AP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.12132525487141E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.62559973762677E-10 |
| Normal-vs-Stage2 |
4.089400E-01 |
| Normal-vs-Stage3 |
5.85087533977457E-14 |
| Normal-vs-Stage4 |
1.06910036379304E-11 |
| Stage1-vs-Stage2 |
3.012400E-01 |
| Stage1-vs-Stage3 |
5.181800E-02 |
| Stage1-vs-Stage4 |
1.392800E-01 |
| Stage2-vs-Stage3 |
9.073900E-02 |
| Stage2-vs-Stage4 |
1.232030E-01 |
| Stage3-vs-Stage4 |
7.019800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.98485672342485E-12 |
| Normal-vs-AfricanAmerican |
4.50129999995941E-06 |
| Normal-vs-Asian |
1.444190E-03 |
| Caucasian-vs-AfricanAmerican |
5.046800E-01 |
| Caucasian-vs-Asian |
8.664600E-01 |
| AfricanAmerican-vs-Asian |
7.177800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.11410003234403E-09 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
4.530200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.344350E-02 |
| Normal-vs-Age(41-60Yrs) |
8.93970000248601E-08 |
| Normal-vs-Age(61-80Yrs) |
1.8925971900785E-12 |
| Normal-vs-Age(81-100Yrs) |
4.621600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.967600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.283000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.086200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.097200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.535200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.106600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.50610000027029E-07 |
| Normal-vs-Grade 2 |
9.56799994789037E-09 |
| Normal-vs-Grade 3 |
3.33066907387547E-16 |
| Normal-vs-Grade 4 |
3.92164078988344E-12 |
| Grade 1-vs-Grade 2 |
2.731200E-01 |
| Grade 1-vs-Grade 3 |
8.475400E-01 |
| Grade 1-vs-Grade 4 |
6.425800E-01 |
| Grade 2-vs-Grade 3 |
1.897770E-01 |
| Grade 2-vs-Grade 4 |
6.142000E-02 |
| Grade 3-vs-Grade 4 |
4.035200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62436730732907E-12 |
| Normal-vs-ccB subtype |
7.256100E-02 |
| ccA subtype-vs-ccB subtype |
1.943720E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.53272999999787E-05 |
| Normal-vs-N1 |
5.48220002727362E-09 |
| N0-vs-N1 |
7.562100E-02 |
|
|
